FDA Inspection
Yash PharmaceuticalsYash Pharmaceuticals – FDA Inspection, Dec 6, 2024
Record Details
This FDA Inspection record concerns Yash Pharmaceuticals, with an inspection on December 6, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · a2bbdc8b-0ef2-4d98-b330-fc9d55382d41
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1257160
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Yash Pharmaceuticals
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Yash Pharmaceuticals
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.